Julian Bailes
Chief Tech/Sci/R&D Officer at BLUE WATER VENTURES INTERNATIONAL, INC.
Profile
Julian Bailes currently works at Psycheceutical Bioscience, Inc., as Director & Chief Medical Officer and Psycheceutical, Inc., as Director & Chief Medical Officer from 2023.
Julian Bailes active positions
Companies | Position | Start |
---|---|---|
BLUE WATER VENTURES INTERNATIONAL, INC. | Chief Tech/Sci/R&D Officer | - |
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Chief Tech/Sci/R&D Officer | 2023-01-09 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
Private companies | 1 |
---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Julian Bailes